Open AccessA comparative study of concomitant boost radiation versus concomitant boost with concurrent chemoradiation versus standard fractionation chemoradiation in locally advanced head-and-neck cancer
Author(s) -
Parul Gupta,
Anil Kumar Dhull,
Vivek Kaushal
Publication year - 2020
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_475_18
Subject(s) - concomitant , medicine , head and neck cancer , radiation therapy , urology , cisplatin , nuclear medicine , toxicity , chemotherapy , dose fractionation , oncology , surgery
As the number of head-and-neck cancer (HNC) patients are high in our subcontinent, the study was designed to reduce the treatment time and increase efficacy.